FDA Approves New Drug to Slow Alzheimer's Disease

The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.

Related Keywords

United States ,Americans ,Teresa Buracchio ,Medicaid Services ,Us Medicare Program ,Centers For Medicare ,Office Of Neuroscience ,Drug Evaluation ,Novel Alzheimer ,Disease Treatment ,Traditional Approval ,Annual Spending ,Its Ancillary Costs ,Alzheimers Disease ,Lzheimer Disease ,Dementia ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Cognitive Deficit ,Memory Problems ,Cognitive Impairment ,Cognition ,Memory ,Medicare ,Brain ,Amyloid Plaque ,Medicaid ,